Clinical Trials Directory

Trials / Terminated

TerminatedNCT02893423

Ropivacaine Transversus Abdominis Plane Blocks for Cesarean Section Analgesia

The Dose Dependent Effect of Ropivacaine Transversus Abdominis Plane Blocks on Postoperative Analgesia After Cesarean Section

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
51 (actual)
Sponsor
Maimonides Medical Center · Academic / Other
Sex
Female
Age
Healthy volunteers
Accepted

Summary

With this research the investigators hope to determine the lowest dose of ropivacaine used in transversus abdominis plane (TAP) blocks that can effectively treat pain in women after cesarean section (c-section).

Detailed description

With this research the investigators hope to determine the lowest dose of ropivacaine used in transversus abdominis plane (TAP) blocks that can effectively treat pain in women after cesarean section (c-section). The TAP is a space between the muscle layers of the abdominal wall that houses nerves supplying the abdominal skin. The investigators will inject the local anesthetic ropivacaine into this space to freeze these nerves and prevent pain following c-section. The investigators will compare three different doses of ropivacaine (0.5%, 0.25%, 0%) to determine the lowest dose that controls pain with the fewest side effects. Participants in this study will receive 0.5% (Group 1), 0.25% (Group 2), or 0% (Group 3) ropivacaine TAP blocks to control pain after c-section. At 2, 6, 12, 24, and 48 hours after cesarean section visual analog pain scores (VAS) for pain on movement, pain at rest, and pain with cough will be collected along with the time to first postoperative analgesic request, patient satisfaction scores, and patient demographics. The analgesic regimen will be considered effective if it provides lower average visual analog scores for pain with movement. Secondary outcomes will be higher patient satisfaction, better pain control, fewer postoperative analgesic requests, and fewer side effects.

Conditions

Interventions

TypeNameDescription
DRUGRopivacaineUsing 2 Different Concentrations of Ropivacaine in Tap Block for Postoperative Analgesia for C-Section Patients

Timeline

Start date
2013-01-01
Primary completion
2016-09-30
Completion
2016-09-30
First posted
2016-09-08
Last updated
2022-09-21
Results posted
2022-09-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02893423. Inclusion in this directory is not an endorsement.